Infectious Disease

What can we help you find?
[[thumbnail_alt_text]]
Originally approved in 2018, baloxavir marboxil is indicated for patients aged 12 years and older.
[[thumbnail_alt_text]]
The new molecules are repurposed form a drug that’s been used for over 80 years.
[[thumbnail_alt_text]]
The objective of the study was to investigate associations between symptoms of gastroenteritis and the presence of airborne norovirus, as well as investigating the size
of norovirus-carrying particles.
[[thumbnail_alt_text]]
Study results suggest that infusing foods with green tea extract may lower consumers' chances of catching norovirus when eating contaminated food.
[[thumbnail_alt_text]]
Pharmacists can play an important role in educating patients about hand hygiene measures during COVID-19.
[[thumbnail_alt_text]]
Cefiderocol approved for the treatment with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
[[thumbnail_alt_text]]
What is causing a young, normally healthy person to suddenly fall ill and need immediate medical attention?
[[thumbnail_alt_text]]
The combination of imipenem-cilastatin and relebactam was previously approved by the FDA to treat patients with complicated urinary tract infections and complicated intra-abdominal infections who have limited or no alternative treatment options.
[[thumbnail_alt_text]]

Remdesivir is not approved by the FDA. However, EUA allows for distribution and emergency use for treatment of COVID-19.
[[thumbnail_alt_text]]
New research on the structure of HIV has revealed a promising novel drug target for treating HIV infection.
[[thumbnail_alt_text]]
Remdesivir is not approved by the FDA nor licensed or approved anywhere in the world.
[[thumbnail_alt_text]]
Case studies focusing on infectious disease.